Skip to main content
Funded Studies

Kevin J. Black, MD

Professor of Psychiatry, of Neurology, of Radiology and of Neuroscience at Washington University School of Medicine

Location: St. Louis, MO United States

Dr. Black is a movement disorders-trained neuropsychiatrist who has cared for individuals with Parkinson's disease (PD) in the Washington University Movement Disorders Center for the past 23 years. He has been a site Principal Investigator (PI) for several clinical trials in PD and holds an investigational new drug application (NDA) for intravenous (IV) levodopa.

For more than 20 years, Dr. Black has been involved in extending dose-response measurements of brain pharmacology through in vivo brain imaging. He was the PI for the single-site study that produced the first human clinical and neuroimaging data on the adenosine A2a antagonist tozadenant (SYN115) in PD, which was also the first published human pharmacological functional magnetic resonance imaging study of any drug candidate developed for clinical use. In a separate line of research, the Black lab developed and patented a novel technique for rapid quantitative pharmacodynamic brain imaging. The current proposal applies that line of work to levodopa pharmacology in PD.

Associated Grants

  • Dopamine Buffering Capacity Measured by phMRI as a Novel Biomarker of Disease Progression in Parkinson's Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.